Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis

NCT00391911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Rhabdomyolysis

Interventions

DRUG: N-Acetylcysteine
OTHER: N-Acetylcystine and Non CRRT
OTHER: Placebo and CRRT
OTHER: Placebo and Non CRRT

Sponsor

Royal Alexandra Hospital

Collaborators

[object Object]
[object Object]